Pioglitazone HCL and Metformin HCL - Pioglitazone HCL and Metformin HCL
Navigation: NDC > Supplier starting with: T > TORRENT PHARMACEUTICALS LIMITED| Field | Value |
|---|---|
| NDC Code: | 13668-281 |
| Proprietary Name: | Pioglitazone HCL and Metformin HCL |
| Suffix: | |
| Non-Proprietary Name: | Pioglitazone HCL and Metformin HCL |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 13-02-2013 |
| Category Name: | ANDA |
| Application Number: | ANDA202001 |
| Labeler: | TORRENT PHARMACEUTICALS LIMITED |
| Substance Name: | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
| Active Numerator Strength: | 850; 15 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
| DEA Schedule: |